Description
Summary of the evidence and consensus-driven guidelines from an international, multidisciplinary panel of experts and a patient advocate. Developed independently of external stakeholder influence, these guidelines aim to increase diagnosis rates and aid the development of expected standards of care.
The guidelines provide key recommendations for the management of CLN2 disease and a framework for holistic and palliative care, emphasising the need for early diagnosis and a coordinated multidisciplinary approach.
EUCAN-BRIN-00193 | June 2025
